Lymphomas News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Roche lymphoma drug drives high remission rate, longer survival ... - Reuters



Reuters
 
Roche lymphoma drug drives high remission rate, longer survival ... 
Reuters
(Reuters) - An experimental Roche Holding AG drug, added to standard therapy, led to a far higher rate of remission and helped patients with an advanced, aggressive blood cancer live significantly longer than the standard treatment alone, according to ...

and more » 


Mogamulizumab superior to vorinostat for cutaneous T-cell lymphoma - Healio



Mogamulizumab superior to vorinostat for cutaneous T-cell lymphoma 
Healio
ATLANTA ? Mogamulizumab demonstrated significantly superior PFS, overall response rate and quality of life compared with vorinostat among patients with previously treated cutaneous T-cell lymphoma, according to results of the phase 3 MAVORIC clinical ...

and more » 


Dr. Younes on Atezolizumab, Obinutuzumab, and Bendamustine in Follicular Lymphoma - OncLive



OncLive
 
Dr. Younes on Atezolizumab, Obinutuzumab, and Bendamustine in Follicular Lymphoma 
OncLive
Anas Younes, MD, Chief of Lymphoma Service, Memorial Sloan Kettering Cancer Center, discusses the interim analysis of a study exploring the safety and efficacy of atezolizumab (Tecentriq) in combination with obinutuzumab (Gazya) and bendamustine in ...

and more » 


Shut-off switch for lymphoma - Science Daily



Shut-off switch for lymphoma 
Science Daily
This is exactly what occurs in T cell Non-Hodgkin's lymphoma. This aggressive form of lymphoma has a very low rate of successful treatment and afflicts approximately one out of every 100,000 persons in Germany. Prof. Jürgen Ruland, Director of the TUM ...

and more » 


Zara is Recovering from Stem Cell Transplant in Her Fight Against ... - Checkbiotech.org (press release)



Checkbiotech.org (press release)
 
Zara is Recovering from Stem Cell Transplant in Her Fight Against ... 
Checkbiotech.org (press release)
Cancer is one of the deadliest terminal disease known to man, primarily when it is not detected early; cancer can be present in different part of the body. It is named after the part of the body, where it is located. It can be classified into benign or ...

and more » 


Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3.5 Year Follow-up ... - Business Wire (press release)



Sustained Benefit in Patients with Relapsed/Refractory Mantle Cell Lymphoma Demonstrated by 3.5 Year Follow-up ... 
Business Wire (press release)
BEERSE, Belgium--(BUSINESS WIRE)--Today, Janssen-Cilag International NV (?Janssen?) announced results of a pooled analysis of relapsed/refractory (r/r) mantle cell lymphoma (MCL) patients treated with Imbruvica® (ibrutinib). The extended follow-up data ...

and more » 


Global CAR T therapy trial shows high rates of durable remission for NHL - EurekAlert (press release)



Global CAR T therapy trial shows high rates of durable remission for NHL 
EurekAlert (press release)
PHILADELPHIA - In a pair of clinical trials stretching from Philadelphia to Tokyo, the chimeric antigen receptor (CAR) T cell therapy Kymriah? (formerly known as CTL019) demonstrated long-lasting remissions in non-Hodgkin's lymphoma (NHL) patients ...

and more » 


Landmark CAR-T cancer study published in the New England ... - EurekAlert (press release)



EurekAlert (press release)
 
Landmark CAR-T cancer study published in the New England ... 
EurekAlert (press release)
Loyola University Medical Center is the only Chicago center that participated in the pivotal clinical trial of a groundbreaking cancer treatment that genetically engineers a patient's immune system to attack cancer cells.

and more » 


Tisagenlecleucel induces durable responses in relapsed, refractory DLBCL - Healio



Tisagenlecleucel induces durable responses in relapsed, refractory DLBCL 
Healio
ATLANTA ? Treatment with the chimeric antigen receptor T-cell therapy tisagenlecleucel led to durable responses among highly pretreated patients with relapsed and refractory diffuse large B-cell lymphoma, according to results of the global JULIET ...

and more » 


Chemotherapy, Radiation Therapy Recommended First for Certain Prostate Cancers, Lymphomas - AJMC.com Managed Markets Network



Chemotherapy, Radiation Therapy Recommended First for Certain Prostate Cancers, Lymphomas 
AJMC.com Managed Markets Network
Chemotherapy and radiation therapy should be the first line of treatment for certain prostate cancers and lymphomas with a major genetic weakness, according to researchers at the University of Virginia School of Medicine. Chemotherapy and radiation ...